The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
13 08 2021
Historique:
received: 07 06 2021
revised: 21 07 2021
accepted: 21 07 2021
entrez: 28 8 2021
pubmed: 29 8 2021
medline: 15 12 2021
Statut: epublish

Résumé

While investigating a signal of adaptive evolution in humans at the gene LARGE, we encountered an intriguing finding by Dr. Stefan Kunz that the gene plays a critical role in Lassa virus binding and entry. This led us to pursue field work to test our hypothesis that natural selection acting on LARGE-detected in the Yoruba population of Nigeria-conferred resistance to Lassa Fever in some West African populations. As we delved further, we conjectured that the "emerging" nature of recently discovered diseases like Lassa fever is related to a newfound capacity for detection, rather than a novel viral presence, and that humans have in fact been exposed to the viruses that cause such diseases for much longer than previously suspected. Dr. Stefan Kunz's critical efforts not only laid the groundwork for this discovery, but also inspired and catalyzed a series of events that birthed Sentinel, an ambitious and large-scale pandemic prevention effort in West Africa. Sentinel aims to detect and characterize deadly pathogens before they spread across the globe, through implementation of its three fundamental pillars: Detect, Connect, and Empower. More specifically, Sentinel is designed to detect known and novel infections rapidly, connect and share information in real time to identify emerging threats, and empower the public health community to improve pandemic preparedness and response anywhere in the world. We are proud to dedicate this work to Stefan Kunz, and eagerly invite new collaborators, experts, and others to join us in our efforts.

Identifiants

pubmed: 34452470
pii: v13081605
doi: 10.3390/v13081605
pmc: PMC8402630
pii:
doi:

Substances chimiques

Receptors, Virus 0
LARGE1 protein, human EC 2.4.1.-
N-Acetylglucosaminyltransferases EC 2.4.1.-

Types de publication

Consensus Development Conference Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM007753
Pays : United States

Références

Emerg Infect Dis. 2005 Oct;11(10):1642-4
pubmed: 16355508
J Virol. 2005 Nov;79(22):14282-96
pubmed: 16254363
Nature. 2020 Jun;582(7811):277-282
pubmed: 32349121
Nature. 2007 Oct 18;449(7164):913-8
pubmed: 17943131
Am J Trop Med Hyg. 1970 Jul;19(4):695-6
pubmed: 4987549
J Virol. 2005 May;79(10):5979-87
pubmed: 15857984
Cell Host Microbe. 2017 Mar 8;21(3):367-375
pubmed: 28238624
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Cell Rep. 2018 May 8;23(6):1806-1816
pubmed: 29742435
Science. 2012 Nov 9;338(6108):750-2
pubmed: 23139320
Science. 2018 Apr 27;360(6387):444-448
pubmed: 29700266
Lancet. 1995 Aug 19;346(8973):472-5
pubmed: 7637481
Cell. 2016 Nov 3;167(4):1088-1098.e6
pubmed: 27814506
N Engl J Med. 2014 Oct 9;371(15):1418-25
pubmed: 24738640
Cell. 2015 Aug 13;162(4):738-50
pubmed: 26276630
PLoS Negl Trop Dis. 2012;6(9):e1839
pubmed: 23029594

Auteurs

Yolanda Botti-Lodovico (Y)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Parvathy Nair (P)

Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

Dolo Nosamiefan (D)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.

Matthew Stremlau (M)

Equator Labs Incorporated, Washington, DC 20011, USA.

Stephen Schaffner (S)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.

Sebastian V Agignoae (SV)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Harvard Kennedy School, Cambridge, MA 02138, USA.

John Oke Aiyepada (JO)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Fehintola V Ajogbasile (FV)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.
Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.

George O Akpede (GO)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.
Department of Medicine, Faculty of Clinical Sciences, College of Medicine, Ambrose Alli University, Ekpoma, Edo State, Nigeria.

Foday Alhasan (F)

Viral Hemorrhagic Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.

Kristian G Andersen (KG)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Scripps Research Translational Institute, La Jolla, CA 92037, USA.

Danny A Asogun (DA)

Ambrose Alli University, Ekpoma, Edo State, Nigeria.

Oladele Oluwafemi Ayodeji (OO)

Federal Medical Centre, Owo, Ondo State, Nigeria.

Aida S Badiane (AS)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Kayla Barnes (K)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.

Matthew R Bauer (MR)

Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.

Antoinette Bell-Kareem (A)

Tulane University Medical Center, New Orleans, LA 70112, USA.

Muoebonam Ekene Benard (ME)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Ebo Ohomoime Benevolence (EO)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Osiemi Blessing (O)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Chloe K Boehm (CK)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Department of Molecular Biology, Princeton University, Princeton, NJ 08540, USA.

Matthew L Boisen (ML)

Zalgen Labs, Germantown, MD 20876, USA.

Nell G Bond (NG)

Tulane University Medical Center, New Orleans, LA 70112, USA.

Luis M Branco (LM)

Zalgen Labs, Germantown, MD 20876, USA.

Michael J Butts (MJ)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.

Amber Carter (A)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Andres Colubri (A)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
University of Massachusetts Medical School, Worcester, MA 01605, USA.

Awa B Deme (AB)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Katherine C DeRuff (KC)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Younousse Diédhiou (Y)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Akhilomen Patience Edamhande (AP)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Siham Elhamoumi (S)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Emily J Engel (EJ)

Tulane University Medical Center, New Orleans, LA 70112, USA.

Philomena Eromon (P)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.

Mosoka Fallah (M)

Refuge Place International, Bassa Town, Lower Johnsonville, Liberia.

Onikepe A Folarin (OA)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.
Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.

Ben Fry (B)

Fathom Information Design, Boston, MA 02114, USA.

Robert Garry (R)

Tulane University Medical Center, New Orleans, LA 70112, USA.

Amy Gaye (A)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Michael Gbakie (M)

Viral Hemorrhagic Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.

Sahr M Gevao (SM)

University of Sierra Leone, Freetown, Sierra Leone.

Gabrielle Gionet (G)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Adrianne Gladden-Young (A)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Augustine Goba (A)

College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Jules Francois Gomis (JF)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Anise N Happi (AN)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.

Mary Houghton (M)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Chikwe Ihekwuazu (C)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Christopher Ojemiega Iruolagbe (CO)

Department of Internal Medicine, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Jonathan Jackson (J)

Dimagi, Inc., Cambridge, MA 02139, USA.

Simbirie Jalloh (S)

College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Jeremy Johnson (J)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Lansana Kanneh (L)

Viral Hemorrhagic Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.

Adeyemi Kayode (A)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.
Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.

Molly Kemball (M)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.

Ojide Chiedozie Kingsley (OC)

Department of Medical Microbiology, Alex-Ekwueme Federal University Teaching Hospital Abakaliki, Abakaliki, Ebonyi, Nigeria.

Veronica Koroma (V)

Viral Hemorrhagic Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.

Dylan Kotliar (D)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.

Samar Mehta (S)

Department of Critical Care Medicine, University of Maryland Medical Center, Baltimore, MA 21201, USA.

Hayden C Metsky (HC)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Airende Michael (A)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Marzieh Ezzaty Mirhashemi (ME)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Kayvon Modjarrad (K)

Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.

Mambu Momoh (M)

College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Eastern Polytechnic College, Kenema, Sierra Leone.

Cameron A Myhrvold (CA)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Department of Molecular Biology, Princeton University, Princeton, NJ 08540, USA.

Okonofua Grace Naregose (OG)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Tolla Ndiaye (T)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Mouhamadou Ndiaye (M)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Aliou Ndiaye (A)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Erica Normandin (E)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.

Ikponmwosa Odia (I)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Judith Uche Oguzie (JU)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.
Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.

Sylvanus A Okogbenin (SA)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Peter O Okokhere (PO)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.
Department of Medicine, Faculty of Clinical Sciences, College of Medicine, Ambrose Alli University, Ekpoma, Edo State, Nigeria.
Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Johnson Okolie (J)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.

Idowu B Olawoye (IB)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.
Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.

Testimony J Olumade (TJ)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.
Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.

Paul E Oluniyi (PE)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.
Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.

Omigie Omoregie (O)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.
West African Examinations Council, Yaba, Lagos State, Nigeria.

Daniel J Park (DJ)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Mariétou Faye Paye (MF)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Brittany Petros (B)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Harvard-MIT Health Sciences and Technology, Cambridge, MA 02139, USA.
Harvard/MIT MD-PhD Program, Boston, MA 02115, USA.

Anthony A Philippakis (AA)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Abechi Priscilla (A)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.

Alan Ricks (A)

MASS Design Group, Boston, MA 02116, USA.
Yale School of Architecture, New Haven, CT 06511, USA.

Anne Rimoin (A)

Department of Epidemiology, Jonathan and Karing Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.

John Demby Sandi (JD)

College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

John S Schieffelin (JS)

Section of Infectious Disease, Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA 70112, USA.

Monica Schreiber (M)

Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.

Mame Cheikh Seck (MC)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Sameed Siddiqui (S)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Katherine Siddle (K)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Allison R Smither (AR)

Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.

Mouhamad Sy (M)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Ngayo Sy (N)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Christopher H Tomkins-Tinch (CH)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.

Oyewale Tomori (O)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Chinedu Ugwu (C)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.
Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.

Jessica N Uwanibe (JN)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.
Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.

Eghosasere Anthonia Uyigue (EA)

Institute of Lassa Fever, Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.

Dada Ireti Victoria (DI)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.
Ikorodu General Hospital, Ikorodu, Lagos State, Nigeria.

Anika Vinzé (A)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Megan E Vodzak (ME)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

Nicole Welch (N)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.

Haja Isatta Wurie (HI)

College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Daba Zoumarou (D)

Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Donald S Grant (DS)

Viral Hemorrhagic Fever Program, Kenema Government Hospital, Ministry of Health and Sanitation, Kenema, Sierra Leone.
College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Daouda Ndiaye (D)

Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.
Université Cheikh Anta Diop, BP 5005, Dakar, Senegal.

Bronwyn MacInnis (B)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.

Pardis C Sabeti (PC)

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.
Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA.
Massachusetts Consortium on Pathogen Readiness, Boston, MA 02115, USA.

Christian Happi (C)

African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.
Department of Biological Sciences, Redeemer's University, Ede, Osun State, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH